Patents by Inventor Glen A. Evans

Glen A. Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030134281
    Abstract: The invention provides a basic genetic operating system for an autonomous prototrophic nanomachine having a nanomachine genome encoding a minimal gene set sufficient for viability. Also provided is a basic genetic operating system for an autonomous auxotrophic nanomachine having a nanomachine genome encoding a minimal gene set sufficient for viability in the presence of an auxotrophic biomolecule. The minimal gene set encoded by the basic genetic operating system can contain the functional categories of transcription, translation, aerobic metabolism, glycolysis/pyruvate dehydrogenase/pentose phosphate pathways, carbohydrate metabolism, central intermediary metabolism, nucleotide metabolism, transport and binding proteins, and housekeeping functions. Functional categories can be arranged in a predetermined physical or temporal order.
    Type: Application
    Filed: September 20, 2001
    Publication date: July 17, 2003
    Inventor: Glen A. Evans
  • Publication number: 20030104385
    Abstract: The present invention provides an isolated human mannosyl transferase and the encoding nucleic acid. Nucleic acids and fragments thereof that correspond to the mannosyl transferase polypeptide similarly are applicable in therapeutic procedures. The invention also provides a human mannosyl transferase fusion polypeptide and a chromosome 9 fusion polypeptide, both of which result from a chromosomal translocation t(9,11) (p24;q23.1). The fusion nucleic acid sequence that encodes the human mannosyl transferase fusion polypeptide and the fusion nucleic acid sequence that encodes the chromosome 9 fusion polypeptide also are provided. The fusion proteins of the invention and their encoding nucleic acids are useful in methods provided by the present invention for diagnosing or predicting the susceptibility to bipolar disorder.
    Type: Application
    Filed: August 2, 2001
    Publication date: June 5, 2003
    Inventor: Glen A. Evans
  • Publication number: 20030087238
    Abstract: The present invention provides a novel approach to utilizing the results of genomic sequence information by computer-directed polynucleotide assembly based upon information available in databases such as the human genome database. Specifically, the present invention can be used to select, synthesize and assemble a novel, synthetic target polynucleotide sequence encoding a target polypeptide. The target polynucleotide can encode a target polypeptide that exhibits enhanced or altered biological activity as compared to a model polypeptide encoded by a natural (wild-type) or model polynucleotide sequence.
    Type: Application
    Filed: August 2, 2001
    Publication date: May 8, 2003
    Inventor: Glen A. Evans
  • Patent number: 6521427
    Abstract: The present invention relates generally to the fields of oligonucleotide synthesis. More particularly, it concerns the assembly of genes and genomes of completely synthetic artificial organisms. Thus, the present invention outlines a novel approach to utilizing the results of genomic sequence information by computer directed gene synthesis based on computing on the human genome database. Specifically, the present invention contemplates and describes the chemical synthesis and resynthesis of genes defined by the genome sequence in a host vector and transfer and expression of these sequences into suitable hosts.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: February 18, 2003
    Assignee: Egea Biosciences, Inc.
    Inventor: Glen A. Evans
  • Patent number: 6238624
    Abstract: A self-addressable, self-assembling microelectronic device is designed and fabricated to actively carry out and control multi-step and multiplex molecular biological reactions in microscopic formats. These reactions include nucleic acid hybridizations, antibody/antigen reactions, diagnostics, and biopolymer synthesis. The device can be fabricated using both microlithographic and micro-machining techniques. The device can electronically control the transport and attachment of specific binding entities to specific micro-locations. The specific binding entities include molecular biological molecules such as nucleic acids and polypeptides. The device can subsequently control the transport and reaction of analytes or reactants at the addressed specific micro-locations. The device is able to concentrate analytes and reactants, remove non-specifically bound molecules, provide stringency control for DNA hybridization reactions, and improve the detection of analytes. The device can be electronically replicated.
    Type: Grant
    Filed: October 4, 1996
    Date of Patent: May 29, 2001
    Assignee: Nanogen, Inc.
    Inventors: Michael J. Heller, Eugene Tu, Glen A. Evans, Ronald G. Sosnowski
  • Patent number: 6175000
    Abstract: In accordance with the present invention, there is provided an isolated peptide having the characteristics of human trithorax protein (as well as DNA encoding same, antisense DNA derived therefrom and antagonists therefor). The invention peptide is characterized by having a DNA binding domain comprising multiple zinc fingers and at least 40% amino acid identity with respect to the DNA binding domain of Drosophila trithorax protein and at least 70% conserved sequence with respect to the DNA binding domain of Drosophila trithorax protein, and wherein said peptide is encoded by a gene located at chromosome 11 of the human genome at q23. Also provided are methods for the treatment of subject(s) suffering from immunodeficiency, developmental abnormality, inherited disease, or cancer by administering to said subject a therapeutically effective amount of one of the above-described agents (i.e., peptide, antagonist therefor, DNA encoding said peptide or antisense DNA derived therefrom).
    Type: Grant
    Filed: May 13, 1993
    Date of Patent: January 16, 2001
    Assignee: The Salk Institute for Biological Studies
    Inventors: Glen A. Evans, Malek Djabali, Licia Selleri, Pauline Parry
  • Patent number: 5891627
    Abstract: Nucleotide sequence defining a polymorphic locus useful for identification of an individual. Also disclosed are oligonucleotide primers useful in amplification of the locus and methods for detecting the amplified locus.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: April 6, 1999
    Assignee: The Salk Institute for Biological Studies
    Inventors: Glen A. Evans, Licia Selleri, James H. Eubanks
  • Patent number: 5851760
    Abstract: The present invention relates to a rapid and powerful sequence "sequence sampled mapping" method for sequencing complex genomes. The invention method is applicable to genomic DNA, preferably mammalian chromosomes, and in a preferred embodiment, employs a "bottom-up" mapping strategy, which allows for the simultaneous analysis of multiple cosmid clones for the detection of overlaps. The sequence sample mapping method is useful first, for the completion of high density sequence-based maps, and ultimately, for the complete sequencing of genomic DNA directly from cosmid clones.
    Type: Grant
    Filed: September 7, 1993
    Date of Patent: December 22, 1998
    Assignee: The Salk Institute for Biological Studies
    Inventors: Glen A. Evans, Michael W. Smith
  • Patent number: 5679517
    Abstract: Methods for identifying the existence, and optionally the location, of chromosomal aberration(s) in the genome of an organism are disclosed. Intact, chromosomal DNA is hybridized with one or more clones constructed from chromosomal DNA derived from an organism of the same species as the organism to be tested. By identifying the existence of a chromosomal aberration, the susceptibility of an individual to certain disease states can be predicted, and/or the nature of a given disease state can be ascertained with greater certainty.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: October 21, 1997
    Assignee: The Salk Institute For Biological Studies
    Inventors: Glen A. Evans, Licia Selleri, Gary G. Hermanson
  • Patent number: 5595469
    Abstract: A transporter vehicle comprises two lifting devices which carry respective jacks and which can be joined at their ends by cross bars to form a rectangular dolly with a central opening therein. The lifting devices each have front and rear wheels so that the dolly can be rolled on floor surfaces. In practice, the two are placed on opposite sides of a load seated on a floor in the opening between those devices, the jacks are placed under the load, the cross bars are assembled with the side frames, the load is jacked up on its opposite sides to be above the floor and the load may then be transported.
    Type: Grant
    Filed: December 6, 1994
    Date of Patent: January 21, 1997
    Assignee: Lucent Technologies Inc.
    Inventor: Glen A. Evans
  • Patent number: 5569013
    Abstract: A transporter vehicle comprises two lifting devices which carry respective jacks and which can be joined at their ends by cross bars to form a rectangular dolly with a central opening therein. The lifting devices each have front and rear wheels so that the dolly can be rolled on floor surfaces. In practice, the two are placed on opposite sides of a load seated on a floor in the opening between those devices, the jacks are placed under the load, the cross bars are assembled with the side frames, the load is jacked up on its opposite sides to be above the floor and the load may then be transported. The jacks may include linkages which cause the load to be lifted wholly vertically while not undergoing any horizontal translational movement.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: October 29, 1996
    Assignee: Lucent Technologies Inc.
    Inventors: Glen A. Evans, Ruloff F. Kip, Jr.
  • Patent number: 5449266
    Abstract: A transporter vehicle comprises two lifting devices which carry respective jacks and which can be joined at their ends by cross bars to form a rectangular dolly with a central opening therein. The lifting devices each have front and rear wheels so that the dolly can be rolled on floor surfaces. In practice, the two are placed on opposite sides of a load seated on a floor in the opening between those devices, the jacks are placed under the load, the cross bars are assembled with the side frames, the load is jacked up on its opposite sides to be above the floor and the load may then be transported.
    Type: Grant
    Filed: December 8, 1993
    Date of Patent: September 12, 1995
    Assignee: AT&T Corp.
    Inventor: Glen A. Evans
  • Patent number: 5445489
    Abstract: A transporter vehicle comprises two lifting devices which carry respective jacks and which can be joined at their ends by cross bars to form a rectangular dolly with a central opening therein. The lifting devices each have front and rear wheels so that the dolly can be rolled on floor surfaces. In practice, the two are placed on opposite sides of a load seated on a floor in the opening between those devices, the jacks are placed under the load, the cross bars are assembled with the side frames, the load is jacked up on its opposite sides to be above the floor and the load may then be transported. The jacks may include linkages which cause the load to be lifted wholly vertically while not undergoing any horizontal translational movement.
    Type: Grant
    Filed: October 14, 1994
    Date of Patent: August 29, 1995
    Assignee: AT&T IPM Corp.
    Inventors: Glen A. Evans, Ruloff F. Kip, Jr.
  • Patent number: 5219726
    Abstract: Method for simultaneous identification of overlapping cosmid clones among multiple cosmid clones and the use of the method for mapping complex genomes are provided. A library of cosmid clones that contains the DNA to be mapped is constructed and arranged in a manner such that individual clones can be identified and replicas of the arranged clones prepared.In preferred embodiments, the clones are arranged in a two dimensional matrix. In such embodiments, the cosmid clones in a row are pooled, mixed probes complementary to the ends of the DNA inserts int he pooled clones are synthesized, hybridized to a first replica of the library. Hybridizing clones, which include the pooled row, are identified. A second portion of clones is prepared by pooling cosmid clones that correspond to a column in the matrix. The second pool thereby includes one clone from the first portion pooled clones. This common clone is located on the replica at the intersection of the column and row.
    Type: Grant
    Filed: June 2, 1989
    Date of Patent: June 15, 1993
    Assignee: The Salk Institute for Biological Studies
    Inventor: Glen A. Evans